{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:08:04Z","timestamp":1794258484236,"version":"4.9.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41581-022-00670-0","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T14:12:42Z","timestamp":1673532762000},"page":"257-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":307,"title":["The role of immune cells and mediators in preeclampsia"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-5978","authenticated-orcid":false,"given":"Evangeline","family":"Deer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Herrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-6499","authenticated-orcid":false,"given":"Denise","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena M.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babbette","family":"LaMarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"670_CR1","doi-asserted-by":"publisher","first-page":"205031211984370","DOI":"10.1177\/2050312119843700","volume":"7","author":"S Braunthal","year":"2019","unstructured":"Braunthal, S. & Brateanu, A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 7, 2050312119843700 (2019).","journal-title":"SAGE Open Med."},{"key":"670_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population\u2010based study. BMC Pregnancy Childbirth 21, 1\u201310 (2021).","journal-title":"BMC Pregnancy Childbirth"},{"key":"670_CR3","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","volume":"11","author":"I Aneman","year":"2020","unstructured":"Aneman, I. et al. Mechanisms of key innate immune cells in early-and late-onset preeclampsia. Front. Immunol. 11, 1864 (2020).","journal-title":"Front. Immunol."},{"key":"670_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175914","volume":"12","author":"M Shen","year":"2017","unstructured":"Shen, M. et al. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS One 12, e0175914 (2017).","journal-title":"PLoS One"},{"key":"670_CR5","doi-asserted-by":"publisher","first-page":"289.e1","DOI":"10.1016\/j.ajog.2021.05.014","volume":"225","author":"AT Papageorghiou","year":"2021","unstructured":"Papageorghiou, A. T. et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am. J. Obstet. Gynecol. 225, 289.e1\u2013289.e17 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/biom10060953","volume":"10","author":"MK Jena","year":"2020","unstructured":"Jena, M. K., Sharma, N. R., Petitt, M., Maulik, D. & Nayak, N. R. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules 10, 953 (2020).","journal-title":"Biomolecules"},{"key":"670_CR7","doi-asserted-by":"publisher","first-page":"100275","DOI":"10.1016\/j.ajogmf.2020.100275","volume":"3","author":"E Deer","year":"2021","unstructured":"Deer, E. et al. Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for angiotensin II type 1 autoantibodies. Am. J. Obstet. Gynecol. MFM 3, 100275 (2021).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"670_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 27, 148\u2013169 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"670_CR9","first-page":"58","volume":"7","author":"C Redman","year":"2017","unstructured":"Redman, C. Early and late onset preeclampsia: two sides of the same coin. Pregnancy Hypertens. 7, 58 (2017).","journal-title":"Pregnancy Hypertens."},{"key":"670_CR10","doi-asserted-by":"crossref","unstructured":"Martin Jr, J. N. & Morris, R. F. in Sex Differences in Cardiovascular Physiology and Pathophysiology 121\u2013136 (Elsevier, 2019).","DOI":"10.1016\/B978-0-12-813197-8.00008-7"},{"key":"670_CR11","doi-asserted-by":"publisher","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","volume":"226","author":"M Fishel Bartal","year":"2020","unstructured":"Fishel Bartal, M. & Sibai, B. M. Eclampsia in the 21st century. Am. J. Obstet. Gynecol. 226, S1237\u2013S1253 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR12","first-page":"593","volume":"11","author":"N Shahzad","year":"2017","unstructured":"Shahzad, N., Irshad, B., Sami, N. & Nadeem, D. Comparison of dexamethasone versus betamethasone for the management of females with HELLP syndrome. Pak. J. Med. Health Sci. 11, 593\u2013597 (2017).","journal-title":"Pak. J. Med. Health Sci."},{"key":"670_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fimmu.2020.00667","volume":"11","author":"V Stojanovska","year":"2020","unstructured":"Stojanovska, V. & Zenclussen, A. C. Innate and adaptive immune responses in HELLP syndrome. Front. Immunol. 11, 667 (2020).","journal-title":"Front. Immunol."},{"key":"670_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/NMC.0000000000000523","volume":"44","author":"K Wisner","year":"2019","unstructured":"Wisner, K. Gestational hypertension and preeclampsia. MCN Am. J. Matern. Child Nurs. 44, 170 (2019).","journal-title":"MCN Am. J. Matern. Child Nurs"},{"key":"670_CR15","doi-asserted-by":"crossref","unstructured":"Burke, S. D. & Karumanchi, S. A. Hypertension 62, 1013\u20131014 (2013).","DOI":"10.1161\/HYPERTENSIONAHA.113.02049"},{"key":"670_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10456-014-9452-3","volume":"18","author":"A Pratt","year":"2015","unstructured":"Pratt, A. et al. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 18, 115\u2013123 (2015).","journal-title":"Angiogenesis"},{"key":"670_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/bs.apha.2016.04.008","volume":"77","author":"JS Possomato-Vieira","year":"2016","unstructured":"Possomato-Vieira, J. S. & Khalil, R. A. Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia. Adv. Pharmacol. 77, 361\u2013431 (2016).","journal-title":"Adv. Pharmacol."},{"key":"670_CR18","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3389\/fimmu.2018.01659","volume":"9","author":"J Geldenhuys","year":"2018","unstructured":"Geldenhuys, J., Rossouw, T. M., Lombaard, H. A., Ehlers, M. M. & Kock, M. M. Disruption in the regulation of immune responses in the placental subtype of preeclampsia. Front. Immunol. 9, 1659 (2018).","journal-title":"Front. Immunol."},{"key":"670_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","volume":"27","author":"R Pijnenborg","year":"2006","unstructured":"Pijnenborg, R., Vercruysse, L. & Hanssens, M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27, 939\u2013958 (2006).","journal-title":"Placenta"},{"key":"670_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/path.1700930218","volume":"93","author":"I Brosens","year":"1967","unstructured":"Brosens, I., Robertson, W. B. & Dixon, H. G. The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93, 569\u2013579 (1967).","journal-title":"J. Pathol. Bacteriol."},{"key":"670_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton, G. J., Woods, A. W., Jauniaux, E. & Kingdom, J. C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30, 473\u2013482 (2009).","journal-title":"Placenta"},{"key":"670_CR22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","volume":"62","author":"F Lyall","year":"2013","unstructured":"Lyall, F., Robson, S. C. & Bulmer, J. N. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62, 1046\u20131054 (2013).","journal-title":"Hypertension"},{"key":"670_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/jwh.2015.5414","volume":"25","author":"D Enkhmaa","year":"2016","unstructured":"Enkhmaa, D. et al. Preeclampsia and vascular function: a window to future cardiovascular disease risk. J. Women\u2019s Health 25, 284\u2013291 (2016).","journal-title":"J. Women\u2019s Health"},{"key":"670_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/1471-0528.15042","volume":"125","author":"AS Cerdeira","year":"2018","unstructured":"Cerdeira, A. S., Agrawal, S., Staff, A. C., Redman, C. W. & Vatish, M. Angiogenic factors: potential to change clinical practice in pre-eclampsia? BJOG 125, 1389\u20131395 (2018).","journal-title":"BJOG"},{"key":"670_CR25","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.7754\/Clin.Lab.2018.180307","volume":"64","author":"TO Bizerea","year":"2018","unstructured":"Bizerea, T. O. et al. The link between selenium, oxidative stress and pregnancy induced hypertensive disorders. Clin. Lab. 64, 1593\u20131610 (2018).","journal-title":"Clin. Lab."},{"key":"670_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fphys.2014.00372","volume":"5","author":"LC S\u00e1nchez-Aranguren","year":"2014","unstructured":"S\u00e1nchez-Aranguren, L. C., Prada, C. E., Ria\u00f1o-Medina, C. E. & Lopez, M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front. Physiol. 5, 372 (2014).","journal-title":"Front. Physiol."},{"key":"670_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fendo.2020.00655","volume":"11","author":"CJ McElwain","year":"2020","unstructured":"McElwain, C. J., Tuboly, E., McCarthy, F. P. & McCarthy, C. M. Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health? Front. Endocrinol. 11, 655 (2020).","journal-title":"Front. Endocrinol."},{"key":"670_CR28","doi-asserted-by":"publisher","first-page":"100275","DOI":"10.1016\/j.ajogmf.2020.100275","volume":"3","author":"E Deer","year":"2021","unstructured":"Deer, E. et al. Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for AT1-AAs. Am. J. Obstet. Gynecol. MFM 3, 100275 (2021).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"670_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri.2017.64","volume":"17","author":"G Mor","year":"2017","unstructured":"Mor, G., Aldo, P. & Alvero, A. B. The unique immunological and microbial aspects of pregnancy. Nat. Rev. Immunol. 17, 469\u2013482 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"670_CR30","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1172\/JCI107462","volume":"52","author":"NF Gant","year":"1973","unstructured":"Gant, N. F., Daley, G. L., Chand, S., Whalley, P. J. & MacDonald, P. C. A study of angiotensin II pressor response throughout primigravid pregnancy. J. Clin. Invest. 52, 2682\u20132689 (1973).","journal-title":"J. Clin. Invest."},{"key":"670_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1034\/j.1600-0412.2003.00206.x","volume":"82","author":"R Madazli","year":"2003","unstructured":"Madazli, R., Aydin, S., Uludag, S., Vildan, O. & Tolun, N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet. Gynecol. Scand. 82, 797\u2013802 (2003).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"670_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-11-59","volume":"11","author":"A Szarka","year":"2010","unstructured":"Szarka, A., Rig\u00f3, J., L\u00e1z\u00e1r, L., Bek\u0151, G. & Molvarec, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 11, 1\u20139 (2010).","journal-title":"BMC Immunol."},{"key":"670_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jri.2005.10.007","volume":"70","author":"Y Jonsson","year":"2006","unstructured":"Jonsson, Y. et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 70, 83\u201391 (2006).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22834","volume":"33","author":"R Aggarwal","year":"2019","unstructured":"Aggarwal, R. et al. Association of pro- and anti-inflammatory cytokines in preeclampsia. J. Clin. Lab. Anal. 33, e22834 (2019).","journal-title":"J. Clin. Lab. Anal."},{"key":"670_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.HYP.0000169152.59854.36","volume":"46","author":"BBD LaMarca","year":"2005","unstructured":"LaMarca, B. B. D., Cockrell, K., Sullivan, E., Bennett, W. & Granger, J. P. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46, 82\u201386 (2005).","journal-title":"Hypertension"},{"key":"670_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0889-8529(18)30059-8","volume":"24","author":"B Formby","year":"1995","unstructured":"Formby, B. Immunologic response in pregnancy: its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol. Metab. Clin. North. Am. 24, 187\u2013205 (1995).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"670_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/01.HYP.0000238442.33463.94","volume":"48","author":"G Gadonski","year":"2006","unstructured":"Gadonski, G. et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48, 711\u2013716 (2006).","journal-title":"Hypertension"},{"key":"670_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.placenta.2012.02.010","volume":"33","author":"J Prins","year":"2012","unstructured":"Prins, J. et al. Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction. Placenta 33, 453\u2013455 (2012).","journal-title":"Placenta"},{"key":"670_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0009-9120(03)00060-2","volume":"36","author":"A Kharfi","year":"2003","unstructured":"Kharfi, A. et al. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin. Biochem. 36, 323\u2013331 (2003).","journal-title":"Clin. Biochem."},{"key":"670_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/01.RES.73.1.205","volume":"73","author":"M Yoshizumi","year":"1993","unstructured":"Yoshizumi, M., Perrella, M. A., Burnett, J. Jr & Lee, M. E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Res. 73, 205\u2013209 (1993).","journal-title":"Circulation Res."},{"key":"670_CR41","first-page":"557","volume":"21","author":"N Maruotti","year":"2006","unstructured":"Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A. & Ribatti, D. Angiogenesis in rheumatoid arthritis. Histol. Histopathol. 21, 557\u2013566 (2006).","journal-title":"Histol. Histopathol."},{"key":"670_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11906-007-0088-1","volume":"9","author":"BD LaMarca","year":"2007","unstructured":"LaMarca, B. D., Ryan, M. J., Gilbert, J. S., Murphy, S. R. & Granger, J. P. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep. 9, 480\u2013485 (2007).","journal-title":"Curr. Hypertens. Rep."},{"key":"670_CR43","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.108.120576","volume":"52","author":"B LaMarca","year":"2008","unstructured":"LaMarca, B. et al. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor \u03b1 in pregnant rats. Hypertension 52, 1168\u20131172 (2008).","journal-title":"Hypertension"},{"key":"670_CR44","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/HYPERTENSIONAHA.108.120881","volume":"52","author":"B LaMarca","year":"2008","unstructured":"LaMarca, B. et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-\u03b1 blockade. Hypertension 52, 1161\u20131167 (2008).","journal-title":"Hypertension"},{"key":"670_CR45","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1152\/ajpregu.00069.2012","volume":"304","author":"SR Murphy","year":"2013","unstructured":"Murphy, S. R., LaMarca, B. B. D., Parrish, M., Cockrell, K. & Granger, J. P. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia\/hypoxia: role of tumor necrosis factor-\u03b1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R130\u2013R135 (2013).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10641955.2020.1793999","volume":"39","author":"MW Cunningham","year":"2020","unstructured":"Cunningham, M. W. et al. Tumor necrosis factor alpha (TNF-\u03b1) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia. Hypertens. Pregnancy 39, 399\u2013404 (2020).","journal-title":"Hypertens. Pregnancy"},{"key":"670_CR47","doi-asserted-by":"publisher","first-page":"R353","DOI":"10.1152\/ajpregu.00051.2012","volume":"303","author":"P Dhillion","year":"2012","unstructured":"Dhillion, P. et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am. J. Physiol. Regulatory Integr. Comp. Physiol. 303, R353\u2013R358 (2012).","journal-title":"Am. J. Physiol. Regulatory Integr. Comp. Physiol."},{"key":"670_CR48","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/JOE-16-0340","volume":"232","author":"D Boeldt","year":"2017","unstructured":"Boeldt, D. & Bird, I. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J. Endocrinol. 232, R27 (2017).","journal-title":"J. Endocrinol."},{"key":"670_CR49","doi-asserted-by":"publisher","first-page":"H969","DOI":"10.1152\/ajpheart.00250.2013","volume":"305","author":"J Krupp","year":"2013","unstructured":"Krupp, J. et al. The loss of sustained Ca2+ signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy. Am. J. Physiol. Heart Circulatory Physiol. 305, H969\u2013H979 (2013).","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"key":"670_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649\u2013658 (2003).","journal-title":"J. Clin. Invest."},{"key":"670_CR51","doi-asserted-by":"publisher","unstructured":"Vishnyakova, P., Elchaninov, A., Fatkhudinov, T. & Sukhikh, G. Role of the monocyte-macrophage system in normal pregnancy and preeclampsia. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20153695 (2019).","DOI":"10.3390\/ijms20153695"},{"key":"670_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.placenta.2017.03.001","volume":"56","author":"MM Faas","year":"2017","unstructured":"Faas, M. M. & de Vos, P. Uterine NK cells and macrophages in pregnancy. Placenta 56, 44\u201352 (2017).","journal-title":"Placenta"},{"key":"670_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/cei.12001","volume":"171","author":"TG Nguyen","year":"2013","unstructured":"Nguyen, T. G., Ward, C. M. & Morris, J. M. To B or not to B cells-mediate a healthy start to life. Clin. Exp. Immunol. 171, 124\u2013134 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"670_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1189\/jlb.1A0815-351R","volume":"100","author":"GE Lash","year":"2016","unstructured":"Lash, G. E. et al. Decidual macrophages: key regulators of vascular remodeling in human pregnancy. J. Leukoc. Biol. 100, 315\u2013325 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"670_CR55","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3389\/fimmu.2019.00792","volume":"10","author":"Y Yao","year":"2019","unstructured":"Yao, Y., Xu, X. H. & Jin, L. Macrophage polarization in physiological and pathological pregnancy. Front. Immunol. 10, 792 (2019).","journal-title":"Front. Immunol."},{"key":"670_CR56","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3389\/fimmu.2018.02628","volume":"9","author":"L Reyes","year":"2018","unstructured":"Reyes, L. & Golos, T. G. Hofbauer cells: their role in healthy and complicated pregnancy. Front. Immunol. 9, 2628 (2018).","journal-title":"Front. Immunol."},{"key":"670_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/plac.1998.0373","volume":"20","author":"F Reister","year":"1999","unstructured":"Reister, F. et al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 20, 229\u2013233 (1999).","journal-title":"Placenta"},{"key":"670_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015080","volume":"98","author":"Y Ma","year":"2019","unstructured":"Ma, Y., Ye, Y., Zhang, J., Ruan, C. C. & Gao, P. J. Immune imbalance is associated with the development of preeclampsia. Medicine 98, e15080 (2019).","journal-title":"Medicine"},{"key":"670_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jfma.2017.03.011","volume":"117","author":"FY Tsao","year":"2018","unstructured":"Tsao, F. Y., Wu, M. Y., Chang, Y. L., Wu, C. T. & Ho, H. N. M1 macrophages decrease in the deciduae from normal pregnancies but not from spontaneous abortions or unexplained recurrent spontaneous abortions. J. Formos. Med. Assoc. 117, 204\u2013211 (2018).","journal-title":"J. Formos. Med. Assoc."},{"key":"670_CR60","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/labinvest.3780326","volume":"81","author":"F Reister","year":"2001","unstructured":"Reister, F. et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab. Invest. 81, 1143\u20131152 (2001).","journal-title":"Lab. Invest."},{"key":"670_CR61","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/imm.13392","volume":"164","author":"S Bert","year":"2021","unstructured":"Bert, S., Ward, E. J. & Nadkarni, S. Neutrophils in pregnancy: new insights into innate and adaptive immune regulation. Immunology 164, 665\u2013676 (2021).","journal-title":"Immunology"},{"key":"670_CR62","doi-asserted-by":"publisher","first-page":"103715","DOI":"10.1016\/j.ebiom.2021.103715","volume":"74","author":"S Dockree","year":"2021","unstructured":"Dockree, S., Shine, B., Pavord, S., Impey, L. & Vatish, M. White blood cells in pregnancy: reference intervals for before and after delivery. EBioMedicine 74, 103715 (2021).","journal-title":"EBioMedicine"},{"key":"670_CR63","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/s-0029-1223285","volume":"26","author":"BJ Canzoneri","year":"2009","unstructured":"Canzoneri, B. J., Lewis, D. F., Groome, L. & Wang, Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am. J. Perinatol. 26, 729\u2013732 (2009).","journal-title":"Am. J. Perinatol."},{"key":"670_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/19336918.2016.1148866","volume":"10","author":"S Giaglis","year":"2016","unstructured":"Giaglis, S. et al. Neutrophil migration into the placenta: good, bad or deadly? Cell Adhes. Migr. 10, 208\u2013225 (2016).","journal-title":"Cell Adhes. Migr."},{"key":"670_CR65","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.humimm.2005.11.003","volume":"66","author":"AK Gupta","year":"2005","unstructured":"Gupta, A. K., Hasler, P., Holzgreve, W., Gebhardt, S. & Hahn, S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum. Immunol. 66, 1146\u20131154 (2005).","journal-title":"Hum. Immunol."},{"key":"670_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00404-005-0093-z","volume":"273","author":"AK Gupta","year":"2006","unstructured":"Gupta, A. K., Gebhardt, S., Hillermann, R., Holzgreve, W. & Hahn, S. Analysis of plasma elastase levels in early and late onset preeclampsia. Arch. Gynecol. Obstet. 273, 239\u2013242 (2006).","journal-title":"Arch. Gynecol. Obstet."},{"key":"670_CR67","doi-asserted-by":"publisher","first-page":"8045161","DOI":"10.1155\/2017\/8045161","volume":"2017","author":"A Bajnok","year":"2017","unstructured":"Bajnok, A., Ivanova, M., Rig\u00f3, J. & Toldi, G. The distribution of activation markers and selectins on peripheral T lymphocytes in preeclampsia. Mediators Inflamm. 2017, 8045161 (2017).","journal-title":"Mediators Inflamm."},{"key":"670_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12020-012-9644-9","volume":"42","author":"AY Goksu Erol","year":"2012","unstructured":"Goksu Erol, A. Y., Nazli, M. & Elis Yildiz, S. Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine 42, 125\u2013131 (2012).","journal-title":"Endocrine"},{"key":"670_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166940","volume":"11","author":"W Yang","year":"2016","unstructured":"Yang, W. et al. miR-125b enhances IL-8 production in early-onset severe preeclampsia by targeting sphingosine-1-phosphate lyase 1. PLoS One 11, e0166940 (2016).","journal-title":"PLoS One"},{"key":"670_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jri.2018.05.002","volume":"127","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia. J. Reprod. Immunol. 127, 48\u201354 (2018).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR71","first-page":"73","volume":"6","author":"I Langers","year":"2012","unstructured":"Langers, I., Renoux, V. M., Thiry, M., Delvenne, P. & Jacobs, N. Natural killer cells: role in local tumor growth and metastasis. Biologics 6, 73\u201382 (2012).","journal-title":"Biologics"},{"key":"670_CR72","doi-asserted-by":"publisher","first-page":"572567","DOI":"10.3389\/fimmu.2020.572567","volume":"11","author":"EF Cornish","year":"2020","unstructured":"Cornish, E. F., Filipovic, I., \u00c5senius, F., Williams, D. J. & McDonnell, T. Innate immune responses to acute viral infection during pregnancy. Front. Immunol. 11, 572567 (2020).","journal-title":"Front. Immunol."},{"key":"670_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.2004.00170.x","volume":"63","author":"A Trundley","year":"2004","unstructured":"Trundley, A. & Moffett, A. Human uterine leukocytes and pregnancy. Tissue Antigens 63, 1\u201312 (2004).","journal-title":"Tissue Antigens"},{"key":"670_CR74","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/intimm\/3.8.743","volume":"3","author":"K Nishikawa","year":"1991","unstructured":"Nishikawa, K. et al. Accumulation of CD16\u2212CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int. Immunol. 3, 743\u2013750 (1991).","journal-title":"Int. Immunol."},{"key":"670_CR75","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0897.2008.00595.x","volume":"59","author":"S Kalkunte","year":"2008","unstructured":"Kalkunte, S. et al. Evolution of non-cytotoxic uterine natural killer cells. Am. J. Reprod. Immunol. 59, 425\u2013432 (2008).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR76","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","volume":"12","author":"J Hanna","year":"2006","unstructured":"Hanna, J. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12, 1065\u20131074 (2006).","journal-title":"Nat. Med."},{"key":"670_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jri.2011.04.006","volume":"90","author":"A Fukui","year":"2011","unstructured":"Fukui, A. et al. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J. Reprod. Immunol. 90, 105\u2013110, (2011).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR78","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.ajpath.2013.08.023","volume":"183","author":"AE Wallace","year":"2013","unstructured":"Wallace, A. E., Host, A. J., Whitley, G. S. & Cartwright, J. E. Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia. Am. J. Pathol. 183, 1853\u20131861 (2013).","journal-title":"Am. J. Pathol."},{"key":"670_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0010-7824(01)00277-3","volume":"65","author":"Z Liu","year":"2002","unstructured":"Liu, Z., Chen, Y., Yang, Y. & Peng, J.-P. The effect on MHC class II expression and apoptosis in placenta by IFN\u03b3 administration. Contraception 65, 177\u2013184 (2002).","journal-title":"Contraception"},{"key":"670_CR80","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/plac.2000.0556","volume":"21","author":"J Greenwood","year":"2000","unstructured":"Greenwood, J. et al. Ultrastructural studies of implantation sites from mice deficient in uterine natural killer cells. Placenta 21, 693\u2013702 (2000).","journal-title":"Placenta"},{"key":"670_CR81","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s43032-020-00212-8","volume":"27","author":"ED Albrecht","year":"2020","unstructured":"Albrecht, E. D. & Pepe, G. J. Regulation of uterine spiral artery remodeling: a review. Reprod. Sci. 27, 1932\u20131942 (2020).","journal-title":"Reprod. Sci."},{"key":"670_CR82","doi-asserted-by":"publisher","first-page":"eaav3866","DOI":"10.1126\/sciimmunol.aav3866","volume":"4","author":"A Sliz","year":"2019","unstructured":"Sliz, A. et al. Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy. Sci. Immunol. 4, eaav3866 (2019).","journal-title":"Sci. Immunol."},{"key":"670_CR83","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.4161\/cc.20542","volume":"11","author":"D Chakraborty","year":"2012","unstructured":"Chakraborty, D., Rumi, M. K. & Soares, M. NK cells, hypoxia and trophoblast cell differentiation. Cell Cycle 11, 2427\u20132430 (2012).","journal-title":"Cell Cycle"},{"key":"670_CR84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000354200","volume":"22","author":"R Raghupathy","year":"2013","unstructured":"Raghupathy, R. Cytokines as key players in the pathophysiology of preeclampsia. Med. Princ. Pract. 22, 8\u201319 (2013).","journal-title":"Med. Princ. Pract."},{"key":"670_CR85","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1089\/jir.2013.0062","volume":"34","author":"HY Liu","year":"2014","unstructured":"Liu, H. Y. et al. High-dose interferon-\u03b3 promotes abortion in mice by suppressing Treg and Th17 polarization. J. Interferon Cytokine Res. 34, 394\u2013403 (2014).","journal-title":"J. Interferon Cytokine Res."},{"key":"670_CR86","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/jir.2006.0106","volume":"27","author":"Q-H Sun","year":"2007","unstructured":"Sun, Q.-H., Peng, J.-P., Xia, H.-F. & Yang, Y. IFN-\u03b3 promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells. J. Interferon Cytokine Res. 27, 567\u2013578 (2007).","journal-title":"J. Interferon Cytokine Res."},{"key":"670_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jri.2009.06.123","volume":"82","author":"H El Costa","year":"2009","unstructured":"El Costa, H. et al. Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. J. Reprod. Immunol. 82, 142\u2013147 (2009).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR88","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20030305","volume":"198","author":"LA Koopman","year":"2003","unstructured":"Koopman, L. A. et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201\u20131212 (2003).","journal-title":"J. Exp. Med."},{"key":"670_CR89","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1172\/JCI43998","volume":"120","author":"SE Hiby","year":"2010","unstructured":"Hiby, S. E. et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 120, 4102\u20134110 (2010).","journal-title":"J. Clin. Invest."},{"key":"670_CR90","first-page":"655","volume":"28","author":"JC Pera\u00e7oli","year":"1995","unstructured":"Pera\u00e7oli, J. C., Fortes, M. R., Rudge, M. V., Rezkallah-Iwasso, M. T. & Pera\u00e7oli, M. T. Studies of natural killer cells in pregnancy-induced hypertension. Braz. J. Med. Biol. Res. 28, 655\u2013661 (1995).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"670_CR91","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1002\/eji.200425929","volume":"35","author":"AM Borzychowski","year":"2005","unstructured":"Borzychowski, A. M., Croy, B. A., Chan, W. L., Redman, C. W. & Sargent, I. L. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur. J. Immunol. 35, 3054\u20133063 (2005).","journal-title":"Eur. J. Immunol."},{"key":"670_CR92","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF02831112","volume":"24","author":"Z Zhang","year":"2004","unstructured":"Zhang, Z. et al. Studies on activity of NK cells in preeclampsia patients. J. Huazhong Univ. Sci. Technol. Med. Sci. 24, 473\u2013475 (2004).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"670_CR93","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-0897.2006.00429.x","volume":"56","author":"N Bachmayer","year":"2006","unstructured":"Bachmayer, N., Rafik Hamad, R., Liszka, L., Bremme, K. & Sverremark-Ekstr\u00f6m, E. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am. J. Reprod. Immunol. 56, 292\u2013301 (2006).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR94","doi-asserted-by":"publisher","first-page":"R1036","DOI":"10.1152\/ajpregu.00285.2019","volume":"318","author":"OK Travis","year":"2020","unstructured":"Travis, O. K. et al. Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 318, R1036\u2013R1046 (2020).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13386","volume":"85","author":"OK Travis","year":"2021","unstructured":"Travis, O. K. et al. Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats. Am. J. Reprod. Immunol. 85, e13386 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR96","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","volume":"17","author":"K Richani","year":"2005","unstructured":"Richani, K. et al. Normal pregnancy is characterized by systemic activation of the complement system. J. Matern. Fetal Neonatal Med. 17, 239\u2013245 (2005).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"670_CR97","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","volume":"47","author":"Z Derzsy","year":"2010","unstructured":"Derzsy, Z., Proh\u00e1szka, Z., Rig\u00f3, J., F\u00fcst, G. & Molvarec, A. Activation of the complement system in normal pregnancy and preeclampsia. Mol. Immunol. 47, 1500\u20131506 (2010).","journal-title":"Mol. Immunol."},{"key":"670_CR98","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","volume":"19","author":"ES Reis","year":"2019","unstructured":"Reis, E. S., Mastellos, D. C., Hajishengallis, G. & Lambris, J. D. New insights into the immune functions of complement. Nat. Rev. Immunol. 19, 503\u2013516 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"670_CR99","doi-asserted-by":"publisher","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","volume":"198","author":"AM Lynch","year":"2008","unstructured":"Lynch, A. M. et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am. J. Obstet. Gynecol. 198, 385.e1\u2013385.e9 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR100","doi-asserted-by":"publisher","first-page":"428.e1","DOI":"10.1016\/j.ajog.2012.02.035","volume":"206","author":"AM Lynch","year":"2012","unstructured":"Lynch, A. M. et al. Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia. Am. J. Obstet. Gynecol. 206, 428.e1\u2013428.e8 (2012).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2013.04.009","volume":"56","author":"KE Lillegard","year":"2013","unstructured":"Lillegard, K. E. et al. Complement activation is critical for placental ischemia-induced hypertension in the rat. Mol. Immunol. 56, 91\u201397 (2013).","journal-title":"Mol. Immunol."},{"key":"670_CR102","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","volume":"132","author":"RM Burwick","year":"2018","unstructured":"Burwick, R. M. et al. Terminal complement activation in preeclampsia. Obstet. Gynecol. 132, 1477\u20131485 (2018).","journal-title":"Obstet. Gynecol."},{"key":"670_CR103","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","volume":"29","author":"R Rampersad","year":"2008","unstructured":"Rampersad, R., Barton, A., Sadovsky, Y. & Nelson, D. M. The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta 29, 855\u2013861 (2008).","journal-title":"Placenta"},{"key":"670_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers, V. M. et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195, 211\u2013220 (2002).","journal-title":"J. Exp. Med."},{"key":"670_CR105","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jri.2012.11.006","volume":"97","author":"KJ Denny","year":"2013","unstructured":"Denny, K. J. et al. Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia. J. Reprod. Immunol. 97, 211\u2013216 (2013).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR106","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/aji.12349","volume":"73","author":"SH Guseh","year":"2015","unstructured":"Guseh, S. H. et al. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia. Am. J. Reprod. Immunol. 73, 437\u2013444 (2015).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/aji.12541","volume":"76","author":"Y He","year":"2016","unstructured":"He, Y. et al. Expression of the complement system\u2019s activation factors in plasma of patients with early\/late-onset severe pre-eclampsia. Am. J. Reprod. Immunol. 76, 205\u2013211 (2016).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","volume":"122","author":"YD He","year":"2020","unstructured":"He, Y. D. et al. Dysregulation of complement system during pregnancy in patients with preeclampsia: a prospective study. Mol. Immunol. 122, 69\u201379 (2020).","journal-title":"Mol. Immunol."},{"key":"670_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13092","volume":"81","author":"JB Larsen","year":"2019","unstructured":"Larsen, J. B. et al. Lectin pathway proteins of the complement system in normotensive pregnancy and pre-eclampsia. Am. J. Reprod. Immunol. 81, e13092 (2019).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR110","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00011-016-0968-4","volume":"65","author":"W Wu","year":"2016","unstructured":"Wu, W. et al. Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China. Inflamm. Res. 65, 837\u2013845 (2016).","journal-title":"Inflamm. Res."},{"key":"670_CR111","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fimmu.2017.00589","volume":"8","author":"AI Lokki","year":"2017","unstructured":"Lokki, A. I. et al. Analysis of complement. Front. Immunol. 8, 589 (2017).","journal-title":"Front. Immunol."},{"key":"670_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001013","volume":"8","author":"JE Salmon","year":"2011","unstructured":"Salmon, J. E. et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 8, e1001013 (2011).","journal-title":"PLoS Med."},{"key":"670_CR113","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","volume":"111","author":"CJ Fang","year":"2008","unstructured":"Fang, C. J. et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111, 624\u2013632 (2008).","journal-title":"Blood"},{"key":"670_CR114","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1001\/jama.1989.03430220066032","volume":"262","author":"HS Klonoff-Cohen","year":"1989","unstructured":"Klonoff-Cohen, H. S., Savitz, D. A., Cefalo, R. C. & McCann, M. F. An epidemiologic study of contraception and preeclampsia. JAMA 262, 3143\u20133147 (1989).","journal-title":"JAMA"},{"key":"670_CR115","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1172\/JCI122182","volume":"128","author":"SA Robertson","year":"2018","unstructured":"Robertson, S. A., Care, A. S. & Moldenhauer, L. M. Regulatory T cells in embryo implantation and the immune response to pregnancy. J. Clin. Invest. 128, 4224\u20134235 (2018).","journal-title":"J. Clin. Invest."},{"key":"670_CR116","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ajog.2015.11.020","volume":"214","author":"P Masoudian","year":"2016","unstructured":"Masoudian, P. et al. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 214, 328\u2013339 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR117","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1189\/jlb.1112603","volume":"94","author":"E Laresgoiti\u2010Servitje","year":"2013","unstructured":"Laresgoiti\u2010Servitje, E. A leading role for the immune system in the pathophysiology of preeclampsia. J. Leukoc. Biol. 94, 247\u2013257 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"670_CR118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","volume":"93","author":"D Darmochwal-Kolarz","year":"2012","unstructured":"Darmochwal-Kolarz, D. et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J. Reprod. Immunol. 93, 75\u201381 (2012).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR119","first-page":"73","volume":"53","author":"K Kondelkova","year":"2010","unstructured":"Kondelkova, K. et al. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med. 53, 73\u201377 (2010).","journal-title":"Acta Med."},{"key":"670_CR120","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1002\/jcp.26604","volume":"233","author":"A Hosseini","year":"2018","unstructured":"Hosseini, A., Dolati, S., Hashemi, V., Abdollahpour\u2010Alitappeh, M. & Yousefi, M. Regulatory T and T helper 17 cells: their roles in preeclampsia. J. Cell. Physiol. 233, 6561\u20136573 (2018).","journal-title":"J. Cell. Physiol."},{"key":"670_CR121","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon, A. C. et al. The role of inflammation in the pathology of preeclampsia. Clin. Sci. 130, 409\u2013419 (2016).","journal-title":"Clin. Sci."},{"key":"670_CR122","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fimmu.2019.00911","volume":"10","author":"N J\u00f8rgensen","year":"2019","unstructured":"J\u00f8rgensen, N., Persson, G. & Hviid, T. V. F. The tolerogenic function of regulatory T cells in pregnancy and cancer. Front. Immunol. 10, 911 (2019).","journal-title":"Front. Immunol."},{"key":"670_CR123","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41577-020-0296-3","volume":"20","author":"LE Lucca","year":"2020","unstructured":"Lucca, L. E. & Dominguez-Villar, M. Modulation of regulatory T cell function and stability by co-inhibitory receptors. Nat. Rev. Immunol. 20, 680\u2013693 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"670_CR124","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jri.2009.05.003","volume":"82","author":"T Tilburgs","year":"2009","unstructured":"Tilburgs, T. et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82, 148\u2013157 (2009).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR125","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.mam.2007.02.006","volume":"28","author":"S Saito","year":"2007","unstructured":"Saito, S., Shiozaki, A., Nakashima, A., Sakai, M. & Sasaki, Y. The role of the immune system in preeclampsia. Mol. Asp. Med. 28, 192\u2013209 (2007).","journal-title":"Mol. Asp. Med."},{"key":"670_CR126","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fimmu.2019.00478","volume":"10","author":"SA Robertson","year":"2019","unstructured":"Robertson, S. A. et al. Therapeutic potential of regulatory T cells in preeclampsia \u2014 opportunities and challenges. Front. Immunol. 10, 478 (2019).","journal-title":"Front. Immunol."},{"key":"670_CR127","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.4049\/jimmunol.0901154","volume":"183","author":"B Santner-Nanan","year":"2009","unstructured":"Santner-Nanan, B. et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 183, 7023\u20137030 (2009).","journal-title":"J. Immunol."},{"key":"670_CR128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2249.2007.03397.x","volume":"149","author":"Y Sasaki","year":"2007","unstructured":"Sasaki, Y. et al. Proportion of peripheral blood and decidual CD4+ CD25bright regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149, 139\u2013145 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"670_CR129","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2019.00573","volume":"10","author":"S Tsuda","year":"2019","unstructured":"Tsuda, S., Nakashima, A., Shima, T. & Saito, S. New paradigm in the role of regulatory T cells during pregnancy. Front. Immunol. 10, 573 (2019).","journal-title":"Front. Immunol."},{"key":"670_CR130","doi-asserted-by":"publisher","first-page":"R1197","DOI":"10.1152\/ajpregu.00623.2011","volume":"302","author":"SR Novotny","year":"2012","unstructured":"Novotny, S. R. et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R1197\u2013R1201 (2012).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR131","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.preghy.2018.10.007","volume":"15","author":"AC Harmon","year":"2019","unstructured":"Harmon, A. C. et al. Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats. Pregnancy Hypertens. 15, 7\u201311 (2019).","journal-title":"Pregnancy Hypertens."},{"key":"670_CR132","doi-asserted-by":"publisher","first-page":"R884","DOI":"10.1152\/ajpregu.00154.2015","volume":"309","author":"DC Cornelius","year":"2015","unstructured":"Cornelius, D. C. et al. An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R884\u2013R891 (2015).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR133","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/HYPERTENSIONAHA.118.10858","volume":"72","author":"AS Care","year":"2018","unstructured":"Care, A. S. et al. Reduction in regulatory T cells in early pregnancy causes uterine artery dysfunction in mice. Hypertension 72, 177\u2013187 (2018).","journal-title":"Hypertension"},{"key":"670_CR134","doi-asserted-by":"publisher","first-page":"F47","DOI":"10.1152\/ajprenal.00398.2020","volume":"320","author":"E Deer","year":"2021","unstructured":"Deer, E. et al. CD4+ T cells cause renal and placental mitochondrial oxidative stress as mechanisms of hypertension in response to placental ischemia. Am. J. Physiol. Renal Physiol. 320, F47\u2013F54 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"670_CR135","first-page":"14873","volume":"2","author":"S Novotny","year":"2013","unstructured":"Novotny, S. et al. CD4+ T cells play a critical role in mediating hypertension in response to placental ischemia. J. Hypertens. Open Access 2, 14873 (2013).","journal-title":"J. Hypertens. Open Access"},{"key":"670_CR136","doi-asserted-by":"publisher","first-page":"99","DOI":"10.37349\/emed.2022.00077","volume":"3","author":"K Reeve","year":"2022","unstructured":"Reeve, K. et al. Placental CD4+ T cells from preeclamptic patients cause autoantibodies to the angiotensin II type I receptor and hypertension in a pregnant rat model of preeclampsia. Exploration Med. 3, 99\u2013111 (2022).","journal-title":"Exploration Med."},{"key":"670_CR137","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3390\/cells10112817","volume":"10","author":"E Deer","year":"2021","unstructured":"Deer, E. et al. Progesterone induced blocking factor reduces hypertension and placental mitochondrial dysfunction in response to sFlt-1 during pregnancy. Cells 10, 2817 (2021).","journal-title":"Cells"},{"key":"670_CR138","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","volume":"13","author":"RP Singh","year":"2014","unstructured":"Singh, R. P. et al. Th17 cells in inflammation and autoimmunity. Autoimmun. Rev. 13, 1174\u20131181 (2014).","journal-title":"Autoimmun. Rev."},{"key":"670_CR139","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","volume":"105","author":"AN Kamali","year":"2019","unstructured":"Kamali, A. N. et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol. Immunol. 105, 107\u2013115 (2019).","journal-title":"Mol. Immunol."},{"key":"670_CR140","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.1073\/pnas.1206322110","volume":"110","author":"B Fu","year":"2013","unstructured":"Fu, B. et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal\u2013fetal interface. Proc. Natl Acad. Sci. 110, E231\u2013E240 (2013).","journal-title":"Proc. Natl Acad. Sci."},{"key":"670_CR141","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/cmi.2014.54","volume":"11","author":"B Fu","year":"2014","unstructured":"Fu, B., Tian, Z. & Wei, H. TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cell. Mol. Immunol. 11, 564\u2013570 (2014).","journal-title":"Cell. Mol. Immunol."},{"key":"670_CR142","doi-asserted-by":"publisher","first-page":"R1192","DOI":"10.1152\/ajpregu.00117.2016","volume":"311","author":"DC Cornelius","year":"2016","unstructured":"Cornelius, D. C. et al. Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 311, R1192\u2013R1199 (2016).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR143","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/cvr\/cvs422","volume":"97","author":"H Nguyen","year":"2013","unstructured":"Nguyen, H. et al. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovascular Res. 97, 696\u2013704 (2013).","journal-title":"Cardiovascular Res."},{"key":"670_CR144","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","volume":"43","author":"SL Gaffen","year":"2008","unstructured":"Gaffen, S. L. An overview of IL-17 function and signaling. Cytokine 43, 402\u2013407 (2008).","journal-title":"Cytokine"},{"key":"670_CR145","doi-asserted-by":"publisher","first-page":"406960","DOI":"10.1155\/2014\/406960","volume":"2014,","author":"QN Dinh","year":"2014","unstructured":"Dinh, Q. N., Drummond, G. R., Sobey, C. G. & Chrissobolis, S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed. Res. Int. 2014, 406960 (2014).","journal-title":"Biomed. Res. Int."},{"key":"670_CR146","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.113.01514","volume":"62","author":"DC Cornelius","year":"2013","unstructured":"Cornelius, D. C. et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62, 1068\u20131073 (2013).","journal-title":"Hypertension"},{"key":"670_CR147","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou, L. et al. TGF-\u03b2-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR\u03b3t function. Nature 453, 236\u2013240 (2008).","journal-title":"Nature"},{"key":"670_CR148","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.4049\/jimmunol.171.10.5406","volume":"171","author":"T Kawahara","year":"2003","unstructured":"Kawahara, T., Ohdan, H., Zhao, G., Yang, Y. G. & Sykes, M. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J. Immunol. 171, 5406\u20135414 (2003).","journal-title":"J. Immunol."},{"key":"670_CR149","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/imr.12754","volume":"288","author":"D Allman","year":"2019","unstructured":"Allman, D., Wilmore, J. R. & Gaudette, B. T. The continuing story of T-cell independent antibodies. Immunol. Rev. 288, 128\u2013135 (2019).","journal-title":"Immunol. Rev."},{"key":"670_CR150","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/aji.12079","volume":"69","author":"D Muzzio","year":"2013","unstructured":"Muzzio, D., Zenclussen, A. C. & Jensen, F. The role of B cells in pregnancy: the good and the bad. Am. J. Reprod. Immunol. 69, 408\u2013412 (2013).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR151","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/HYPERTENSIONAHA.111.188276","volume":"59","author":"F Jensen","year":"2012","unstructured":"Jensen, F. et al. CD19+CD5+ cells as indicators of preeclampsia. Hypertension 59, 861\u2013868 (2012).","journal-title":"Hypertension"},{"key":"670_CR152","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI4106","volume":"103","author":"G Wallukat","year":"1999","unstructured":"Wallukat, G. et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103, 945\u2013952 (1999).","journal-title":"J. Clin. Invest."},{"key":"670_CR153","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/14767050903019593","volume":"22","author":"M Torricelli","year":"2009","unstructured":"Torricelli, M. et al. Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia. J. Matern. Fetal Neonatal Med. 22, 993\u2013999 (2009).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"670_CR154","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3109\/01443615.2010.503908","volume":"30","author":"MI Nor Azlin","year":"2010","unstructured":"Nor Azlin, M. I. et al. Thyroid autoantibodies and associated complications during pregnancy. J. Obstet. Gynaecol. 30, 675\u2013678 (2010).","journal-title":"J. Obstet. Gynaecol."},{"key":"670_CR155","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.HYP.0000256565.20983.d4","volume":"49","author":"CA Hubel","year":"2007","unstructured":"Hubel, C. A. et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49, 612\u2013617 (2007).","journal-title":"Hypertension"},{"key":"670_CR156","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jri.2018.05.008","volume":"128","author":"AB Rieber-Mohn","year":"2018","unstructured":"Rieber-Mohn, A. B. et al. Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum. J. Reprod. Immunol. 128, 23\u201329 (2018).","journal-title":"J. Reprod. Immunol."},{"key":"670_CR157","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/aji.12154","volume":"70","author":"B Zeng","year":"2013","unstructured":"Zeng, B., Kwak-Kim, J., Liu, Y. & Liao, A. H. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation. Am. J. Reprod. Immunol. 70, 454\u2013463 (2013).","journal-title":"Am. J. Reprod. Immunol."},{"key":"670_CR158","doi-asserted-by":"publisher","first-page":"R1243","DOI":"10.1152\/ajpregu.00273.2015","volume":"309","author":"DC Cornelius","year":"2015","unstructured":"Cornelius, D. C. et al. Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R1243\u2013R1250 (2015).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR159","doi-asserted-by":"publisher","first-page":"S867","DOI":"10.1016\/j.ajog.2021.11.019","volume":"226","author":"P-Y Robillard","year":"2022","unstructured":"Robillard, P.-Y., Dekker, G., Scioscia, M. & Saito, S. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia. Am. J. Obstet. Gynecol. 226, S867\u2013S875 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR160","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1080\/14767058.2021.1918666","volume":"35","author":"P-Y Robillard","year":"2021","unstructured":"Robillard, P.-Y. Epidemiological evidence that severe obese women (pre-pregnancy BMI\u2265 40 kg\/m2) should lose weight during their pregnancy. J. Matern. Fetal Neonatal Med. 35, 6618\u20136623 (2021).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"670_CR161","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","volume":"101","author":"R Dechend","year":"2000","unstructured":"Dechend, R. et al. AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101, 2382\u20132387 (2000).","journal-title":"Circulation"},{"key":"670_CR162","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2016.08.016","volume":"78","author":"JF Regal","year":"2016","unstructured":"Regal, J. F. et al. Role of IgM and angiotensin II type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. Mol. Immunol. 78, 38\u201347 (2016).","journal-title":"Mol. Immunol."},{"key":"670_CR163","doi-asserted-by":"publisher","unstructured":"Murphy, S. R. & Cockrell, K. Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia\/hypoxia: role of angiotensin II. Physiol. Rep. 3, https:\/\/doi.org\/10.14814\/phy2.12310 (2015).","DOI":"10.14814\/phy2.12310"},{"key":"670_CR164","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","volume":"82","author":"A Quan","year":"2006","unstructured":"Quan, A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum. Dev. 82, 23\u201328 (2006).","journal-title":"Early Hum. Dev."},{"key":"670_CR165","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/HYPERTENSIONAHA.113.02362","volume":"63","author":"SE Elliott","year":"2014","unstructured":"Elliott, S. E. et al. Characterization of antibody specificities associated with preeclampsia. Hypertension 63, 1086\u20131093 (2014).","journal-title":"Hypertension"},{"key":"670_CR166","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.111.171348","volume":"58","author":"K Wenzel","year":"2011","unstructured":"Wenzel, K. et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 58, 77\u201384 (2011).","journal-title":"Hypertension"},{"key":"670_CR167","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1084\/jem.20090872","volume":"206","author":"RA Irani","year":"2009","unstructured":"Irani, R. A. et al. The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia. J. Exp. Med. 206, 2809\u20132822 (2009).","journal-title":"J. Exp. Med."},{"key":"670_CR168","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1071-5576(02)00259-9","volume":"10","author":"Y Xia","year":"2003","unstructured":"Xia, Y., Wen, H., Bobst, S., Day, M. C. & Kellems, R. E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J. Soc. Gynecol. Investig. 10, 82\u201393 (2003).","journal-title":"J. Soc. Gynecol. Investig."},{"key":"670_CR169","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/01.CIR.0000142855.68398.3A","volume":"110","author":"TM Thway","year":"2004","unstructured":"Thway, T. M. et al. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 110, 1612\u20131619 (2004).","journal-title":"Circulation"},{"key":"670_CR170","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.113.01648","volume":"62","author":"J Brewer","year":"2013","unstructured":"Brewer, J. et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension 62, 886\u2013892 (2013).","journal-title":"Hypertension"},{"key":"670_CR171","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.117.10681","volume":"71","author":"MW Cunningham","year":"2018","unstructured":"Cunningham, M. W. et al. AT1-AA (Angiotensin II Type 1 receptor agonistic autoantibody) blockade prevents preeclamptic symptoms in placental ischemic rats. Hypertension 71, 886\u2013893 (2018).","journal-title":"Hypertension"},{"key":"670_CR172","doi-asserted-by":"publisher","first-page":"R256","DOI":"10.1152\/ajpregu.00179.2019","volume":"318","author":"VR Vaka","year":"2020","unstructured":"Vaka, V. R. et al. Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 318, R256\u2013R262 (2020).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"670_CR173","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10641955.2020.1833215","volume":"39","author":"JW Duncan","year":"2020","unstructured":"Duncan, J. W. et al. Angiotensin II type 1 receptor autoantibody blockade improves cerebral blood flow autoregulation and hypertension in a preclinical model of preeclampsia. Hypertens. Pregnancy 39, 451\u2013460 (2020).","journal-title":"Hypertens. Pregnancy"},{"key":"670_CR174","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/rheumatology\/keh616","volume":"44","author":"GS Panayi","year":"2005","unstructured":"Panayi, G. S. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology 44, ii3\u2013ii7 (2005).","journal-title":"Rheumatology"},{"key":"670_CR175","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","volume":"143","author":"G Cianchini","year":"2007","unstructured":"Cianchini, G. et al. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch. Dermatol. 143, 1033\u20131038 (2007).","journal-title":"Arch. Dermatol."},{"key":"670_CR176","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2133.2007.07982.x","volume":"157","author":"G Cianchini","year":"2007","unstructured":"Cianchini, G. et al. Severe persistent pemphigoid gestationis: long-term remission with rituximab. Br. J. Dermatol. 157, 388\u2013389 (2007).","journal-title":"Br. J. Dermatol."},{"key":"670_CR177","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/HYPERTENSIONAHA.110.167569","volume":"57","author":"B LaMarca","year":"2011","unstructured":"LaMarca, B. et al. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 57, 865\u2013871 (2011).","journal-title":"Hypertension"},{"key":"670_CR178","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","volume":"117","author":"EF Chakravarty","year":"2011","unstructured":"Chakravarty, E. F., Murray, E. R., Kelman, A. & Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 117, 1499\u20131506 (2011).","journal-title":"Blood"},{"key":"670_CR179","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000453","volume":"5","author":"G Das","year":"2018","unstructured":"Das, G. et al. Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD. Neurol. Neuroimmunol. Neuroinflamm. 5, e453 (2018).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"670_CR180","doi-asserted-by":"publisher","unstructured":"Smith, J. B. et al. Rituximab, MS, and pregnancy. Neurol. Neuroimmunol. Neuroinflamm. 7, https:\/\/doi.org\/10.1212\/NXI.0000000000000734 (2020).","DOI":"10.1212\/NXI.0000000000000734"},{"key":"670_CR181","first-page":"1426","volume":"91","author":"B Friedrichs","year":"2006","unstructured":"Friedrichs, B. et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91, 1426\u20131427 (2006).","journal-title":"Haematologica"},{"key":"670_CR182","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","volume":"44","author":"AJ Vaught","year":"2016","unstructured":"Vaught, A. J. et al. Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome. Exp. Hematol. 44, 390\u2013398 (2016).","journal-title":"Exp. Hematol."},{"key":"670_CR183","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","volume":"62","author":"RM Burwick","year":"2013","unstructured":"Burwick, R. M., Fichorova, R. N., Dawood, H. Y., Yamamoto, H. S. & Feinberg, B. B. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension 62, 1040\u20131045 (2013).","journal-title":"Hypertension"},{"key":"670_CR184","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/jcm8030407","volume":"8","author":"V Stefanovic","year":"2019","unstructured":"Stefanovic, V. The extended use of eculizumab in pregnancy and complement activation-associated diseases affecting maternal, fetal and neonatal kidneys \u2014 the future is now? J. Clin. Med. 8, 407 (2019).","journal-title":"J. Clin. Med."},{"key":"670_CR185","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2020.00548","volume":"11","author":"AI Lokki","year":"2020","unstructured":"Lokki, A. I., Haapio, M. & Heikkinen-Eloranta, J. Eculizumab treatment for postpartum HELLP syndrome and aHUS \u2014 case report. Front. Immunol. 11, 548 (2020).","journal-title":"Front. Immunol."},{"key":"670_CR186","doi-asserted-by":"publisher","first-page":"S1171","DOI":"10.1016\/j.ajog.2020.08.040","volume":"226","author":"DD Smith","year":"2020","unstructured":"Smith, D. D. & Costantine, M. M. The role of statins in the prevention of preeclampsia. Am. J. Obstet. Gynecol. 226, S1171\u2013S1181 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"670_CR187","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1172\/JCI86957","volume":"126","author":"E Lefkou","year":"2016","unstructured":"Lefkou, E. et al. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J. Clin. Investig. 126, 2933\u20132940 (2016).","journal-title":"J. Clin. Investig."},{"key":"670_CR188","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613\u2013622 (2017).","journal-title":"N. Engl. J. Med."},{"key":"670_CR189","doi-asserted-by":"crossref","unstructured":"Dodd, J. M., Jones, L., Flenady, V., Cincotta, R. & Crowther, C. A. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst. Rev. (2013).","DOI":"10.1002\/14651858.CD004947.pub3"},{"key":"670_CR190","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.preghy.2020.09.002","volume":"22","author":"LM Amaral","year":"2020","unstructured":"Amaral, L. M. et al. 17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats. Pregnancy Hypertens. 22, 151\u2013155 (2020).","journal-title":"Pregnancy Hypertens."},{"key":"670_CR191","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","volume":"58","author":"J Singh","year":"2011","unstructured":"Singh, J., Ahmed, A. & Girardi, G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension 58, 716\u2013724 (2011).","journal-title":"Hypertension"},{"key":"670_CR192","doi-asserted-by":"publisher","first-page":"F614","DOI":"10.1152\/ajprenal.00410.2003","volume":"288","author":"DM Shah","year":"2005","unstructured":"Shah, D. M. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am. J. Physiol. Renal Physiol. 288, F614\u2013F625 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"670_CR193","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/HYPERTENSIONAHA.107.091322","volume":"50","author":"Y Xia","year":"2007","unstructured":"Xia, Y., Ramin, S. M. & Kellems, R. E. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50, 269\u2013275 (2007).","journal-title":"Hypertension"},{"key":"670_CR194","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/HYPERTENSIONAHA.116.07971","volume":"68","author":"MW Cunningham","year":"2016","unstructured":"Cunningham, M. W. et al. Agonistic autoantibodies to the angiotensin II type 1 receptor enhance angiotensin II-induced renal vascular sensitivity and reduce renal function during pregnancy. Hypertension 68, 1308\u20131313 (2016).","journal-title":"Hypertension"},{"key":"670_CR195","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/abbs\/gmv088","volume":"47","author":"W Zhang","year":"2015","unstructured":"Zhang, W. et al. Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta. Acta Biochim. Biophys. Sin. 47, 851\u2013856 (2015).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"670_CR196","doi-asserted-by":"publisher","unstructured":"Singh, K. D. et al. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers. Proc. Natl Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2019126118 (2021).","DOI":"10.1073\/pnas.2019126118"},{"key":"670_CR197","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.109.137935","volume":"54","author":"B LaMarca","year":"2009","unstructured":"LaMarca, B. et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54, 905\u2013909 (2009).","journal-title":"Hypertension"},{"key":"670_CR198","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ajh.2011.62","volume":"24","author":"MR Parrish","year":"2011","unstructured":"Parrish, M. R. et al. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am. J. Hypertens. 24, 835\u2013840 (2011).","journal-title":"Am. J. Hypertens."},{"key":"670_CR199","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","volume":"14","author":"CC Zhou","year":"2008","unstructured":"Zhou, C. C. et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14, 855\u2013862 (2008).","journal-title":"Nat. Med."},{"key":"670_CR200","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/ajh.2010.70","volume":"23","author":"MR Parrish","year":"2010","unstructured":"Parrish, M. R. et al. The effect of immune factors, tumor necrosis factor-\u03b1, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 23, 911\u2013916 (2010).","journal-title":"Am. J. Hypertens."},{"key":"670_CR201","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.RES.0000254703.11154.18","volume":"100","author":"CC Zhou","year":"2007","unstructured":"Zhou, C. C. et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ. Res. 100, 88\u201395 (2007).","journal-title":"Circ. Res."},{"key":"670_CR202","first-page":"38","volume":"25","author":"CC Zhou","year":"2006","unstructured":"Zhou, C. C. Upregulation of placental soluble fms-like tyrosine kinase 1 by AT1 receptor agonistic autoantibodies in preeclampsia. Hypertens. Pregnancy 25, 38 (2006).","journal-title":"Hypertens. Pregnancy"},{"key":"670_CR203","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.109.902890","volume":"121","author":"CC Zhou","year":"2010","unstructured":"Zhou, C. C. et al. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-\u03b1 induction contributes to increased soluble endoglin production in preeclampsia. Circulation 121, 436\u2013444 (2010).","journal-title":"Circulation"},{"key":"670_CR204","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2018.11.004","volume":"15","author":"MW Cunningham","year":"2019","unstructured":"Cunningham, M. W. et al. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. Pregnancy Hypertens. 15, 72\u201377 (2019).","journal-title":"Pregnancy Hypertens."},{"key":"670_CR205","first-page":"1159","volume":"21","author":"ZC Wang","year":"2017","unstructured":"Wang, Z. C. et al. Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells. Eur. Rev. Med. Pharmacol. Sci. 21, 1159\u20131168 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"670_CR206","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/01.CIR.0000058200.90059.B1","volume":"107","author":"R Dechend","year":"2003","unstructured":"Dechend, R. et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107, 1632\u20131639 (2003).","journal-title":"Circulation"},{"key":"670_CR207","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.118.11290","volume":"72","author":"VR Vaka","year":"2018","unstructured":"Vaka, V. R. et al. Role of mitochondrial dysfunction and reactive oxygen species in mediating hypertension in the reduced uterine perfusion pressure rat model of preeclampsia. Hypertension 72, 703\u2013711 (2018).","journal-title":"Hypertension"},{"key":"670_CR208","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.genm.2011.04.003","volume":"8","author":"MR Parrish","year":"2011","unstructured":"Parrish, M. R. et al. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend. Med. 8, 184\u2013188 (2011).","journal-title":"Gend. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00670-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:10:39Z","timestamp":1679847039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":208,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1038\/s41581-022-00670-0","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"8 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}